A real life study of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in Argentina
Latest Information Update: 25 Jun 2021
At a glance
- Drugs Golimumab (Primary) ; Golimumab (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 25 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism.